Hemangiopericytoma

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Hemangiopericytoma
Classification and external resources
ICD-O: 9150

WikiDoc Resources for

Hemangiopericytoma

Articles

Most recent articles on Hemangiopericytoma

Most cited articles on Hemangiopericytoma

Review articles on Hemangiopericytoma

Articles on Hemangiopericytoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hemangiopericytoma

Images of Hemangiopericytoma

Photos of Hemangiopericytoma

Podcasts & MP3s on Hemangiopericytoma

Videos on Hemangiopericytoma

Evidence Based Medicine

Cochrane Collaboration on Hemangiopericytoma

Bandolier on Hemangiopericytoma

TRIP on Hemangiopericytoma

Clinical Trials

Ongoing Trials on Hemangiopericytoma at Clinical Trials.gov

Trial results on Hemangiopericytoma

Clinical Trials on Hemangiopericytoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hemangiopericytoma

NICE Guidance on Hemangiopericytoma

NHS PRODIGY Guidance

FDA on Hemangiopericytoma

CDC on Hemangiopericytoma

Books

Books on Hemangiopericytoma

News

Hemangiopericytoma in the news

Be alerted to news on Hemangiopericytoma

News trends on Hemangiopericytoma

Commentary

Blogs on Hemangiopericytoma

Definitions

Definitions of Hemangiopericytoma

Patient Resources / Community

Patient resources on Hemangiopericytoma

Discussion groups on Hemangiopericytoma

Patient Handouts on Hemangiopericytoma

Directions to Hospitals Treating Hemangiopericytoma

Risk calculators and risk factors for Hemangiopericytoma

Healthcare Provider Resources

Symptoms of Hemangiopericytoma

Causes & Risk Factors for Hemangiopericytoma

Diagnostic studies for Hemangiopericytoma

Treatment of Hemangiopericytoma

Continuing Medical Education (CME)

CME Programs on Hemangiopericytoma

International

Hemangiopericytoma en Espanol

Hemangiopericytoma en Francais

Businness

Hemangiopericytoma in the Marketplace

Patents on Hemangiopericytoma

Experimental / Informatics

List of terms related to Hemangiopericytoma

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Hemangiopericytomas, along with hemangioendotheliomas and angiosarcomas are tumors that arise from vascular structures. A hemangiopericytoma (HPC) is a type of soft tissue sarcoma that originates in the pericytes in the walls of capillaries (they arise from the cells of Zimmerman, which surround vessels). Both benign and malignant forms are encountered. These tumors are most frequently seen in middle-aged adults.

Typically they have large vessels especially located at its periphery, and commonly involve the lower limbs (35% of cases), especially the thigh, pelvis and retroperitoneum (25%)

Primary osseous lesions are rare.

Diagnosis

Radiologically they appear the same as angiosarcomas and heemangioendotheliomas.

X-rays

Nonspecific soft tissue mass. When involving bone, they are predominatly lytic, and may mimic hemangiomas with a course honeycomb appearance.

Angiography

Dense, well-circumscribed areas of enhancement with early draining veins and shunting. Hemangiopericytoma are described as having a pedicle formed by the arteries supplying the tumor from which vessels branch to encircle the tumor.

Multi Sliced CT

Non specific soft tissue mass, with density similar to muscle but demonstrating bright contrast enhancement. CTA may demonstrate large feeding vessels.

MRI

Brightly enhancing soft tissue mass, often hyperintense on T2WI, with prominent flow voids, most marked in haemangiopericytomas.

References

  • Murphy M. et al "Musculoskeletal Angiomatous Lesions" RadioGraphics: July 1, 1995 -- Volume 15, Number 4

External links


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools